NCT04674371

Brief Summary

It has now been 90 years since Werner Forssmann developed the CVC. Nowadays CVCs play an integral role for critically ill patients. Despite the high number of central venous access devices inserted annually, there are limited data on the incidence of the associated procedural complications, many of which carry substantial clinical risk. This point was highlighted in recently published Association of Anaesthetists of Great Britain and Ireland "Safe vascular access 2016" guidelines and "Clinical guidelines on central venous catheterisation" in 2014 of the Swedish Society of Anaesthesiology and Intensive Care Medicine. This German point prevalence study should identify the number of central venous catheter insertions and the incidence of various and especially serious mechanical complications across multiple hospital sites within one day. Secondary aims are to identify the availability of resources and infrastructure to facilitate safe central venous catheter insertion and management of potential complications. As much hospital sites as possible should participate and identify all adult central venous catheter insertions, with subsequent review of any complications detected. Additionally, resources while inserting the CVC should be specified such as ultrasound for assessment of ultrasound anatomy and/or ultrasound-guidance. Furthermore, assessment of the CVC tip should be studied whether done during CVC placement with

  • ECG-guidance or by
  • transthoracic/transesophageal ultrasound with the Microbubble test or more conventional post hoc with
  • bedside chest X-ray Any mechanical complication should be documented untill day three post insertion. The background is to identify possible perforations due to initially unfavorable CVC tip positions (angle \> 40 ° to wall of the superior vena cava). Participation in the study is open to all disciplines (anesthesia, intensive care, internal medicine, surgery, etc.) that regularly perform CVCs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
537

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 19, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

May 17, 2022

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
Last Updated

August 10, 2022

Status Verified

May 1, 2022

Enrollment Period

3 days

First QC Date

December 13, 2020

Last Update Submit

August 7, 2022

Conditions

Keywords

Central venous cathetercentral venous lineCatheterization, Central Venous / accessCatheterization, Central Venous / methodsCatheterization, Central Venous / instrumentationCatheterization, Central Venous / adverse effectsPlacement of larger cathetersInsertion of CVCsComplication of CVCsCVC misplacementUltrasonography, Interventional / adverse effectsUltrasonography, Interventional / instrumentationUltrasonography, Interventional / methodsElectroctrocardiography, Radiography, Echocardiographie/ TEEVascular Access Devices / standardsVascular Access Devices / trendsCritical Illness / therapyHumansAdults, Adolescents

Outcome Measures

Primary Outcomes (2)

  • Patients Demographics

    All patients with a CVC Insertion on May 17th. 2022 in participating Hospitals independent of sex, age or BMI in kg/m\^2 are eligible

    17.05.2022

  • Complications and malpositions

    Which complications and malpositions occur within 72 h

    17.05.2022-20.05.2022

Secondary Outcomes (8)

  • Percentage of the emergency procedure

    17.05.2022

  • Distribution of the vessel sites und sides

    17.05.2022

  • Experience of the operator

    17.05.2022

  • Puncture attempts

    17.05.2022

  • Type and caliber of catheter

    17.05.2022

  • +3 more secondary outcomes

Interventions

Every operator should perform the CVC Insertion Procedure according to his common clinical practice.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Over 2000 patients in Germany

You may qualify if:

  • Adults
  • Young Adults
  • Children
  • Infants
  • Neonates

You may not qualify if:

  • None
  • Procedures
  • Elective central venous access procedures
  • Emergency central venous access procedures
  • None
  • Providers
  • Anesthesiologists
  • Internist
  • Neurologist
  • Surgeon
  • Etc.
  • None
  • Selection of catheter insertion site
  • External jugular
  • Internal jugular
  • +22 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.

Mitte, 10117, Germany

Location

Related Publications (7)

  • Schmidt GA, Blaivas M, Conrad SA, Corradi F, Koenig S, Lamperti M, Saugel B, Schummer W, Slama M. Ultrasound-guided vascular access in critical illness. Intensive Care Med. 2019 Apr;45(4):434-446. doi: 10.1007/s00134-019-05564-7. Epub 2019 Feb 18.

    PMID: 30778648BACKGROUND
  • McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33. doi: 10.1056/NEJMra011883. No abstract available.

    PMID: 12646670BACKGROUND
  • Schummer W, Sakka SG, Huttemann E, Reinhart K, Schummer C. [Ultrasound guidance for placement control of central venous catheterization. Survey of 802 anesthesia departments for 2007 in Germany]. Anaesthesist. 2009 Jul;58(7):677-85. doi: 10.1007/s00101-009-1569-1. German.

    PMID: 19547936BACKGROUND
  • Frykholm P, Pikwer A, Hammarskjold F, Larsson AT, Lindgren S, Lindwall R, Taxbro K, Oberg F, Acosta S, Akeson J. Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2014 May;58(5):508-24. doi: 10.1111/aas.12295. Epub 2014 Mar 5.

    PMID: 24593804BACKGROUND
  • Coe AJ. AAGBI Safe vascular access guidelines I. Anaesthesia. 2016 Aug;71(8):985. doi: 10.1111/anae.13553. No abstract available.

    PMID: 27396261BACKGROUND
  • Bierman S. AAGBI safe vascular access guidelines II. Anaesthesia. 2016 Aug;71(8):985-6. doi: 10.1111/anae.13554. No abstract available.

    PMID: 27396262BACKGROUND
  • Lathey RK, Jackson RE, Bodenham A, Harper D, Patle V; Anaesthetic Audit and Research Matrix of Yorkshire (AARMY). A multicentre snapshot study of the incidence of serious procedural complications secondary to central venous catheterisation. Anaesthesia. 2017 Mar;72(3):328-334. doi: 10.1111/anae.13774. Epub 2016 Dec 16.

    PMID: 27981565BACKGROUND

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Wolfram Schummer, MD, PhD

    Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PD Dr. med. Dr. med. habil.

Study Record Dates

First Submitted

December 13, 2020

First Posted

December 19, 2020

Study Start

May 17, 2022

Primary Completion

May 20, 2022

Study Completion

May 20, 2022

Last Updated

August 10, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations